Mammalian homolog
HsMAD2L1
HsCCNE1
HsMAPKAPK2
HsSLC29A1
HsBAF53A
HsFK506-bp1
HsTMSB4X
HsDUT
HsEEF1G
HsIARS
HsIPO7
HsSCYE1
HsBUB3
MmMYB
HsCCT4
HsCDC2
HsLMNB1
MmFATP
HsCCNK
HsHARS
HsASH2L
HsMetAP2
HsSRPR
HsNotch2
HsTTC4
HsNOP5/NOP58
HsEGR1
HsPRDX4
HsNUP98
HsDDX5
HsCDC20
HsTGFBI
HsNAB1
HsHSPB2
HsRFC4
HsRAN
HsEEF1A1
MmNr2f1
HsERCC1
HsCSNK2B
HsGSTT1
HsMINPP1
HsSNRPF
HsRRM2
HsSNRPD3
HsMCM3
HsPLK
HsCCNA1
HsMCM2
HsKIF11
Reference
[1]
[2, 3]
[4, 5]
[6]
[7]
[8]
[9]
[10]
[11]
[12]
[13]
[14, 15]
[16]
[17]
[18]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27, 28]
[29]
[30]
[31, 32]
[33]
[34]
[35]
[36]
[37]
[38]
[39, 40]
[41]
[42]
[43]
[44]
[45]
[46]
[47]
[48]
[49]
[50]
[49]
[51]
[52]
[19, 52-56]
[19, 51, 57]
[58, 59]
HsPCNA
HsSKP2
HsFBL
HsCDC25B
HsCCNB1
HsCDK7
HsEEF1D
HsATF4
HsKLKB1
HsTUBB2
HsSPARC
HsMYC
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
[19, 60]
[61-63]
[49, 64]
[65-68]
[69, 70]
[71]
[72]
[73]
[74]
[75]
[76]
[50, 64, 77]
Percy MJ, Myrie KA, Neeley CK, Azim JN, Ethier SP, Petty EM: Expression
and mutational analyses of the human MAD2L1 gene in breast cancer
cells. Genes Chromosomes Cancer 2000, 29(4):356-362.
Keyomarsi K, O'Leary N, Molnar G, Lees E, Fingert HJ, Pardee AB: Cyclin E,
a potential prognostic marker for breast cancer. Cancer Res 1994,
54(2):380-385.
Keyomarsi K, Tucker SL, Buchholz TA, Callister M, Ding Y, Hortobagyi GN,
Bedrosian I, Knickerbocker C, Toyofuku W, Lowe M et al: Cyclin E and
survival in patients with breast cancer. N Engl J Med 2002, 347(20):15661575.
Han Q, Leng J, Bian D, Mahanivong C, Carpenter KA, Pan ZK, Han J, Huang
S:
Rac1-MKK3-p38-MAPKAPK2
pathway
promotes
urokinase
plasminogen activator mRNA stability in invasive breast cancer cells. J
Biol Chem 2002, 277(50):48379-48385.
Salh B, Marotta A, Wagey R, Sayed M, Pelech S: Dysregulation of
phosphatidylinositol 3-kinase and downstream effectors in human breast
cancer. Int J Cancer 2002, 98(1):148-154.
Mackey JR, Jennings LL, Clarke ML, Santos CL, Dabbagh L, Vsianska M,
Koski SL, Coupland RW, Baldwin SA, Young JD et al: Immunohistochemical
variation of human equilibrative nucleoside transporter 1 protein in
primary breast cancers. Clin Cancer Res 2002, 8(1):110-116.
Decristofaro MF, Betz BL, Rorie CJ, Reisman DN, Wang W, Weissman BE:
Characterization of SWI/SNF protein expression in human breast cancer
cell lines and other malignancies. J Cell Physiol 2001, 186(1):136-145.
Khatua S, Peterson KM, Brown KM, Lawlor C, Santi MR, LaFleur B, Dressman
D, Stephan DA, MacDonald TJ: Overexpression of the EGFR/FKBP12/HIF2alpha pathway identified in childhood astrocytomas by angiogenesis
gene profiling. Cancer Res 2003, 63(8):1865-1870.
Mohler JL, Morris TL, Ford OH, 3rd, Alvey RF, Sakamoto C, Gregory CW:
Identification of differentially expressed genes associated with
androgen-independent growth of prostate cancer. Prostate 2002,
51(4):247-255.
Fleischmann J, Kremmer E, Muller S, Sommer P, Kirchner T, Niedobitek G,
Grasser FA: Expression of deoxyuridine triphosphatase (dUTPase) in
colorectal tumours. Int J Cancer 1999, 84(6):614-617.
Ender B, Lynch P, Kim YH, Inamdar NV, Cleary KR, Frazier ML:
Overexpression of an elongation factor-1 gamma-hybridizing RNA in
colorectal adenomas. Mol Carcinog 1993, 7(1):18-20.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
Miyaki M, Iijima T, Shiba K, Aki T, Kita Y, Yasuno M, Mori T, Kuroki T, Iwama
T: Alterations of repeated sequences in 5' upstream and coding regions
in colorectal tumors from patients with hereditary nonpolyposis
colorectal cancer and Turcot syndrome. Oncogene 2001, 20(37):52155218.
Li SR, Gyselman VG, Dorudi S, Bustin SA: Elevated levels of RanBP7
mRNA in colorectal carcinoma are associated with increased
proliferation and are similar to the transcription pattern of the protooncogene c-myc. Biochem Biophys Res Commun 2000, 271(2):537-543.
Kao J, Houck K, Fan Y, Haehnel I, Libutti SK, Kayton ML, Grikscheit T, Chabot
J, Nowygrod R, Greenberg S et al: Characterization of a novel tumorderived cytokine. Endothelial-monocyte activating polypeptide II. J Biol
Chem 1994, 269(40):25106-25119.
Berger AC, Tang G, Alexander HR, Libutti SK: Endothelial monocyteactivating polypeptide II, a tumor-derived cytokine that plays an
important role in inflammation, apoptosis, and angiogenesis. J
Immunother 2000, 23(5):519-527.
Grabsch H, Takeno S, Parsons WJ, Pomjanski N, Boecking A, Gabbert HE,
Mueller W: Overexpression of the mitotic checkpoint genes BUB1,
BUBR1, and BUB3 in gastric cancer--association with tumour cell
proliferation. J Pathol 2003, 200(1):16-22.
You C, Xu X, Cal B, Zhang S: [Expression and implication of c-myb and
bcl-2 proteins in C6 gliomas]. Hua Xi Yi Ke Da Xue Xue Bao 2000,
31(3):304-305, 318.
Yokota S, Yamamoto Y, Shimizu K, Momoi H, Kamikawa T, Yamaoka Y,
Yanagi H, Yura T, Kubota H: Increased expression of cytosolic chaperonin
CCT in human hepatocellular and colonic carcinoma. Cell Stress
Chaperones 2001, 6(4):345-350.
Qin LX, Tang ZY: The prognostic molecular markers in hepatocellular
carcinoma. World J Gastroenterol 2002, 8(3):385-392.
Lim SO, Park SJ, Kim W, Park SG, Kim HJ, Kim YI, Sohn TS, Noh JH, Jung
G: Proteome analysis of hepatocellular carcinoma. Biochem Biophys Res
Commun 2002, 291(4):1031-1037.
Blask DE, Sauer LA, Dauchy RT, Holowachuk EW, Ruhoff MS, Kopff HS:
Melatonin inhibition of cancer growth in vivo involves suppression of
tumor fatty acid metabolism via melatonin receptor-mediated signal
transduction events. Cancer Res 1999, 59(18):4693-4701.
Lundquist A, Barre B, Bienvenu F, Hermann J, Avril S, Coqueret O: Kaposi
sarcoma-associated viral cyclin K overrides cell growth inhibition
mediated by oncostatin M through STAT3 inhibition. Blood 2003,
101(10):4070-4077.
Vazquez-Abad D, Carson JH, Rothfield N: Localization of histidyl-tRNA
synthetase (Jo-1) in human laryngeal epithelial carcinoma cell line (HEp2 cells). Cell Tissue Res 1996, 286(3):487-491.
Wang J, Zhou Y, Yin B, Du G, Huang X, Li G, Shen Y, Yuan J, Qiang B:
ASH2L: alternative splicing and downregulation during induced
megakaryocytic differentiation of multipotential leukemia cell lines. J Mol
Med 2001, 79(7):399-405.
Kanno T, Endo H, Takeuchi K, Morishita Y, Fukayama M, Mori S: High
expression of methionine aminopeptidase type 2 in germinal center B
cells and their neoplastic counterparts. Lab Invest 2002, 82(7):893-901.
26.
27.
28.
29.
30.
31.
32.
33.
34.
35.
36.
37.
38.
39.
40.
Wang WS, Chen PM, Hsiao HL, Ju SY, Su Y: Overexpression of the
thymosin beta-4 gene is associated with malignant progression of
SW480 colon cancer cells. Oncogene 2003, 22(21):3297-3306.
Hubmann R, Schwarzmeier JD, Shehata M, Hilgarth M, Duechler M, Dettke M,
Berger R: Notch2 is involved in the overexpression of CD23 in B-cell
chronic lymphocytic leukemia. Blood 2002, 99(10):3742-3747.
Sriuranpong V, Borges MW, Ravi RK, Arnold DR, Nelkin BD, Baylin SB, Ball
DW: Notch signaling induces cell cycle arrest in small cell lung cancer
cells. Cancer Res 2001, 61(7):3200-3205.
Poetsch M, Dittberner T, Cowell JK, Woenckhaus C: TTC4, a novel
candidate tumor suppressor gene at 1p31 is often mutated in malignant
melanoma of the skin. Oncogene 2000, 19(50):5817-5820.
Nakamoto K, Ito A, Watabe K, Koma Y, Asada H, Yoshikawa K, Shinomura Y,
Matsuzawa Y, Nojima H, Kitamura Y: Increased expression of a nucleolar
Nop5/Sik family member in metastatic melanoma cells: evidence for its
role in nucleolar sizing and function. Am J Pathol 2001, 159(4):1363-1374.
Gaggioli C, Deckert M, Aberdam E, Ortonne JP, Ballotti R, Tartare-Deckert S:
SP-05 Differential Regulation of Egr-1 by HGF/SF in Melanocytes and
Melanoma cells. Pigment Cell Res 2003, 16(5):573-574.
Yang SZ, Abdulkadir SA: Early growth response gene 1 modulates
androgen receptor signaling in prostate carcinoma cells. J Biol Chem
2003, 278(41):39906-39911.
Kinnula VL, Lehtonen S, Sormunen R, Kaarteenaho-Wiik R, Kang SW, Rhee
SG, Soini Y: Overexpression of peroxiredoxins I, II, III, V, and VI in
malignant mesothelioma. J Pathol 2002, 196(3):316-323.
Pineault N, Buske C, Feuring-Buske M, Abramovich C, Rosten P, Hogge DE,
Aplan PD, Humphries RK: Induction of acute myeloid leukemia in mice by
the human leukemia-specific fusion gene NUP98-HOXD13 in concert with
Meis1. Blood 2003, 101(11):4529-4538.
Stone B, Schummer M, Paley PJ, Thompson L, Stewart J, Ford M, Crawford
M, Urban N, O'Briant K, Nelson BH: Serologic analysis of ovarian tumor
antigens reveals a bias toward antigens encoded on 17q. Int J Cancer
2003, 104(1):73-84.
Li D, Zhu J, Firozi PF, Abbruzzese JL, Evans DB, Cleary K, Friess H, Sen S:
Overexpression of oncogenic STK15/BTAK/Aurora A kinase in human
pancreatic cancer. Clin Cancer Res 2003, 9(3):991-997.
Schneider D, Kleeff J, Berberat PO, Zhu Z, Korc M, Friess H, Buchler MW:
Induction and expression of betaig-h3 in pancreatic cancer cells. Biochim
Biophys Acta 2002, 1588(1):1-6.
Abdulkadir SA, Qu Z, Garabedian E, Song SK, Peters TJ, Svaren J, Carbone
JM, Naughton CK, Catalona WJ, Ackerman JJ et al: Impaired prostate
tumorigenesis in Egr1-deficient mice. Nat Med 2001, 7(1):101-107.
Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, Fordham
M, Neoptolemos JP, Ke Y, Foster CS: Heat shock protein expression
independently predicts clinical outcome in prostate cancer. Cancer Res
2000, 60(24):7099-7105.
Takashi M, Katsuno S, Sakata T, Ohshima S, Kato K: Different
concentrations of two small stress proteins, alphaB crystallin and HSP27
in human urological tumor tissues. Urol Res 1998, 26(6):395-399.
41.
42.
43.
44.
45.
46.
47.
48.
49.
50.
51.
52.
53.
54.
55.
56.
Chaib H, Cockrell EK, Rubin MA, Macoska JA: Profiling and verification of
gene expression patterns in normal and malignant human prostate
tissues by cDNA microarray analysis. Neoplasia 2001, 3(1):43-52.
Li P, Yu X, Ge K, Melamed J, Roeder RG, Wang Z: Heterogeneous
expression and functions of androgen receptor co-factors in primary
prostate cancer. Am J Pathol 2002, 161(4):1467-1474.
Xu K, Luduena RF: Characterization of nuclear betaII-tubulin in tumor
cells: a possible novel target for taxol. Cell Motil Cytoskeleton 2002,
53(1):39-52.
Li A, Zhu X, Brown B, Craft CM: Gene expression networks underlying
retinoic acid-induced differentiation of human retinoblastoma cells.
Invest Ophthalmol Vis Sci 2003, 44(3):996-1007.
Cheng L, Sturgis EM, Eicher SA, Spitz MR, Wei Q: Expression of nucleotide
excision repair genes and the risk for squamous cell carcinoma of the
head and neck. Cancer 2002, 94(2):393-397.
Takano T, Hasegawa Y, Miyauchi A, Matsuzuka F, Yoshida H, Kuma K,
Hayashi N, Nakamori S, Amino N: Quantitative analysis of osteonectin
mRNA in thyroid carcinomas. Endocr J 2002, 49(4):511-516.
Morari EC, Leite JL, Granja F, da Assumpcao LV, Ward LS: The null
genotype of glutathione s-transferase M1 and T1 locus increases the risk
for thyroid cancer. Cancer Epidemiol Biomarkers Prev 2002, 11(11):14851488.
Gimm O, Chi H, Dahia PL, Perren A, Hinze R, Komminoth P, Dralle H,
Reynolds PR, Eng C: Somatic mutation and germline variants of MINPP1,
a phosphatase gene located in proximity to PTEN on 10q23.3, in follicular
thyroid carcinomas. J Clin Endocrinol Metab 2001, 86(4):1801-1805.
Hashimoto K, Azuma C, Tokugawa Y, Nobunaga T, Aki TA, Matsui Y,
Yanagida T, Izumi H, Saji F, Murata Y: Loss of H19 imprinting and upregulation of H19 and SNRPN in a case with malignant mixed Mullerian
tumor of the uterus. Hum Pathol 1997, 28(7):862-865.
Karlsson A, Helou K, Walentinsson A, Hedrich HJ, Szpirer C, Levan G:
Amplification of Mycn, Ddx1, Rrm2, and Odc1 in rat uterine endometrial
carcinomas. Genes Chromosomes Cancer 2001, 31(4):345-356.
Ishimi Y, Okayasu I, Kato C, Kwon HJ, Kimura H, Yamada K, Song SY:
Enhanced expression of Mcm proteins in cancer cells derived from
uterine cervix. Eur J Biochem 2003, 270(6):1089-1101.
Holtrich U, Wolf G, Brauninger A, Karn T, Bohme B, Rubsamen-Waigmann H,
Strebhardt K: Induction and down-regulation of PLK, a human
serine/threonine kinase expressed in proliferating cells and tumors. Proc
Natl Acad Sci U S A 1994, 91(5):1736-1740.
Yam CH, Fung TK, Poon RY: Cyclin A in cell cycle control and cancer. Cell
Mol Life Sci 2002, 59(8):1317-1326.
Chen HM, Yen-Ping Kuo M, Lin KH, Lin CY, Chiang CP: Expression of cyclin
A is related to progression of oral squamous cell carcinoma in Taiwan.
Oral Oncol 2003, 39(5):476-482.
Nguyen DC, Parsa B, Close A, Magnusson B, Crowe DL, Sinha UK:
Overexpression of cell cycle regulatory proteins correlates with
advanced tumor stage in head and neck squamous cell carcinomas. Int J
Oncol 2003, 22(6):1285-1290.
Shih HC, Shiozawa T, Kato K, Imai T, Miyamoto T, Uchikawa J, Nikaido T,
Konishi I: Immunohistochemical expression of cyclins, cyclin-dependent
57.
58.
59.
60.
61.
62.
63.
64.
65.
66.
67.
68.
69.
70.
kinases, tumor-suppressor gene products, Ki-67, and sex steroid
receptors in endometrial carcinoma: positive staining for cyclin A as a
poor prognostic indicator. Hum Pathol 2003, 34(5):471-478.
Todorov IT, Werness BA, Wang HQ, Buddharaju LN, Todorova PD, Slocum
HK, Brooks JS, Huberman JA: HsMCM2/BM28: a novel proliferation marker
for human tumors and normal tissues. Lab Invest 1998, 78(1):73-78.
Hansen GM, Justice MJ: Activation of Hex and mEg5 by retroviral
insertion may contribute to mouse B-cell leukemia. Oncogene 1999,
18(47):6531-6539.
Kaiser A, Brembeck FH, Nicke B, Wiedenmann B, Riecken EO, Rosewicz S:
All-trans-retinoic acid-mediated growth inhibition involves inhibition of
human kinesin-related protein HsEg5. J Biol Chem 1999, 274(27):1892518931.
Nikitakis NG, Lopes MA, Bailey JS, Blanchaert RH, Jr., Ord RA, Sauk JJ: Oral
leiomyosarcoma: review of the literature and report of two cases with
assessment of the prognostic and diagnostic significance of
immunohistochemical and molecular markers. Oral Oncol 2002, 38(2):201208.
Harper JW: Protein destruction: adapting roles for Cks proteins. Curr Biol
2001, 11(11):R431-435.
Shigemasa K, Gu L, O'Brien TJ, Ohama K: Skp2 overexpression is a
prognostic factor in patients with ovarian adenocarcinoma. Clin Cancer
Res 2003, 9(5):1756-1763.
Penin RM, Fernandez-Figueras MT, Puig L, Rex J, Ferrandiz C, Ariza A:
Over-expression of p45(SKP2) in Kaposi's sarcoma correlates with
higher tumor stage and extracutaneous involvement but is not directly
related to p27(KIP1) down-regulation. Mod Pathol 2002, 15(11):1227-1235.
Soldani C, Bottone MG, Biggiogera M, Alpini C, Scovassi AI, Martin T,
Pellicciari C: Nuclear localization of phosphorylated c-Myc protein in
human tumor cells. Eur J Histochem 2002, 46(4):377-380.
Reis-Filho JS, Torio B, Albergaria A, Schmitt FC: p63 expression in normal
skin and usual cutaneous carcinomas. J Cutan Pathol 2002, 29(9):517-523.
Pelosi G, Pasini F, Olsen Stenholm C, Pastorino U, Maisonneuve P, Sonzogni
A, Maffini F, Pruneri G, Fraggetta F, Cavallon A et al: p63 immunoreactivity
in lung cancer: yet another player in the development of squamous cell
carcinomas? J Pathol 2002, 198(1):100-109.
Kaufmann O, Fietze E, Mengs J, Dietel M: Value of p63 and cytokeratin 5/6
as immunohistochemical markers for the differential diagnosis of poorly
differentiated and undifferentiated carcinomas. Am J Clin Pathol 2001,
116(6):823-830.
Di Como CJ, Urist MJ, Babayan I, Drobnjak M, Hedvat CV, Teruya-Feldstein J,
Pohar K, Hoos A, Cordon-Cardo C: p63 expression profiles in human
normal and tumor tissues. Clin Cancer Res 2002, 8(2):494-501.
Yasuda M, Takesue F, Inutsuka S, Honda M, Nozoe T, Korenaga D:
Overexpression of cyclin B1 in gastric cancer and its clinicopathological
significance: an immunohistological study. J Cancer Res Clin Oncol 2002,
128(8):412-416.
Hassan KA, Ang KK, El-Naggar AK, Story MD, Lee JI, Liu D, Hong WK, Mao
L: Cyclin B1 overexpression and resistance to radiotherapy in head and
neck squamous cell carcinoma. Cancer Res 2002, 62(22):6414-6417.
71.
72.
73.
74.
75.
76.
77.
Bartkova J, Zemanova M, Bartek J: Expression of CDK7/CAK in normal and
tumor cells of diverse histogenesis, cell-cycle position and
differentiation. Int J Cancer 1996, 66(6):732-737.
Kolettas E, Lymboura M, Khazaie K, Luqmani Y: Modulation of elongation
factor-1 delta (EF-1 delta) expression by oncogenes in human epithelial
cells. Anticancer Res 1998, 18(1A):385-392.
Bowers AJ, Scully S, Boylan JF: SKIP3, a novel Drosophila tribbles
ortholog, is overexpressed in human tumors and is regulated by
hypoxia. Oncogene 2003, 22(18):2823-2835.
Rae F, Bulmer B, Nicol D, Clements J: The human tissue kallikreins (KLKs
1-3) and a novel KLK1 mRNA transcript are expressed in a renal cell
carcinoma cDNA library. Immunopharmacology 1999, 45(1-3):83-88.
Gapany M, Faust RA, Tawfic S, Davis A, Adams GL, Ahmed K: Association
of elevated protein kinase CK2 activity with aggressive behavior of
squamous cell carcinoma of the head and neck. Mol Med 1995, 1(6):659666.
Bradshaw AD, Sage EH: SPARC, a matricellular protein that functions in
cellular differentiation and tissue response to injury. J Clin Invest 2001,
107(9):1049-1054.
Pelengaris S, Khan M, Evan G: c-MYC: more than just a matter of life and
death. Nat Rev Cancer 2002, 2(10):764-776.